The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties - PubMed (original) (raw)

Comparative Study

The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties

J R Gage et al. J Virol. 1990 Feb.

Abstract

The E7 early viral protein of the oncogenic human papillomavirus type 16 (HPV-16) has been strongly implicated in the maintenance of the malignant phenotype in cervical cancers and cancer-derived cell lines. HPV-16 E7 is a nuclear phosphoprotein that can cooperate with ras to transform baby rat kidney cells, transactivates the adenovirus E2 promoter, and binds to the retinoblastoma (RB) protein. The E7 phosphoprotein of the nononcogenic HPV-6b, which is generally associated with benign genital warts, is similar to the HPV-16 E7 in amino acid sequence but differs dramatically in migration in sodium dodecyl sulfate-polyacrylamide gels, sedimentation in nondenaturing glycerol gradients, and the ability to bind the RB protein. Our results indicate that the RB protein preferentially binds the phosphorylated form of HPV-6b E7, which comprises a minor fraction of the total E7 expressed in transiently transfected COS-7 cells. These characteristics may help to explain the difference in the oncogenic potential of the oncogenic and nononcogenic types of genital papillomaviruses.

PubMed Disclaimer

Cited by

Identification of three transforming proteins encoded by cottontail rabbit papillomavirus.
Meyers C, Harry J, Lin YL, Wettstein FO. Meyers C, et al. J Virol. 1992 Mar;66(3):1655-64. doi: 10.1128/JVI.66.3.1655-1664.1992. J Virol. 1992. PMID: 1310771 Free PMC article.
The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL, Martinez-Yamout MA, Liao R, Sun P, Dyson HJ, Wright PE. Jansma AL, et al. J Mol Biol. 2014 Dec 12;426(24):4030-4048. doi: 10.1016/j.jmb.2014.10.021. Epub 2014 Nov 1. J Mol Biol. 2014. PMID: 25451029 Free PMC article.
Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation.
Xiong Y, Kuppuswamy D, Li Y, Livanos EM, Hixon M, White A, Beach D, Tlsty TD. Xiong Y, et al. J Virol. 1996 Feb;70(2):999-1008. doi: 10.1128/JVI.70.2.999-1008.1996. J Virol. 1996. PMID: 8551641 Free PMC article.
Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites.
Snijders PJ, van den Brule AJ, Schrijnemakers HF, Raaphorst PM, Meijer CJ, Walboomers JM. Snijders PJ, et al. J Virol. 1992 May;66(5):3172-8. doi: 10.1128/JVI.66.5.3172-3178.1992. J Virol. 1992. PMID: 1313922 Free PMC article.
Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins.
Sang BC, Barbosa MS. Sang BC, et al. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8063-7. doi: 10.1073/pnas.89.17.8063. Proc Natl Acad Sci U S A. 1992. PMID: 1325643 Free PMC article.

References

1. Virology. 1988 Jul;165(1):134-40 - PubMed
1. Science. 1988 Jul 8;241(4862):218-21 - PubMed
1. Cell. 1988 Jul 15;54(2):275-83 - PubMed
1. Virology. 1988 Oct;166(2):624-7 - PubMed
1. Cell. 1989 Jan 13;56(1):57-65 - PubMed

The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties - PubMed (original) (raw)